Subject
Neurology (clinical),Neurology,General Medicine
Reference35 articles.
1. Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study;Arru;Mult. Scler.,2014
2. Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients with Multiple Sclerosis (ANGEL-MS). [online] Clinicaltrials.gov. 2020. Available at: 3. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family;Blond;J. Virol.,1999
4. Corticosteroids for the long-term treatment in multiple sclerosis;Ciccone;Cochrane Database Syst Rev.,2008
5. Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS. [online] Clinicaltrials.gov. 2020. Available at: .
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献